Stockscreener 앱 받기
1.14
0.88%
0.01
전일 마감가:
$1.13
열려 있는:
$1.12
하루 거래량:
1.16M
Relative Volume:
0.39
시가총액:
$865.34M
수익:
$606.88M
순이익/손실:
$-225.68M
주가수익비율:
-3.7723
EPS:
-0.3022
순현금흐름:
$-190.82M
1주 성능:
-2.56%
1개월 성능:
-8.06%
6개월 성능:
-25.97%
1년 성능:
-30.91%
1일 변동 폭
$1.11
$1.15
1주일 범위
$1.095
$1.18
52주 변동 폭
$1.095
$1.64
Opko Health Inc Stock (OPK) Company Profile
명칭
Opko Health Inc
전화
305-575-4181
주소
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.14 | 865.34M | 606.88M | -225.68M | -190.82M | -0.3022 |
TMO
Thermo Fisher Scientific Inc
|
491.46 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.55 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.48 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.24 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-20 | 개시 | JP Morgan | Neutral |
| 2025-10-31 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-04-25 | 개시 | JP Morgan | Neutral |
| 2023-06-29 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | 개시 | H.C. Wainwright | Buy |
| 2022-01-24 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | 개시 | Ladenburg Thalmann | Buy |
| 2019-11-25 | 개시 | Piper Jaffray | Overweight |
| 2018-03-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-09-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2016-06-21 | 재확인 | Standpoint Research | Buy |
| 2016-06-03 | 개시 | Standpoint Research | Buy |
| 2016-03-31 | 재확인 | Barrington Research | Outperform |
| 2015-10-16 | 개시 | JP Morgan | Overweight |
| 2015-09-11 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-03-03 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2014-05-12 | 재확인 | Oppenheimer | Outperform |
| 2014-03-14 | 개시 | Oppenheimer | Outperform |
| 2013-11-13 | 재확인 | Ladenburg Thalmann | Buy |
| 2013-05-30 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-10-22 | 개시 | Barrington Research | Outperform |
| 2011-12-01 | 재확인 | Ladenburg Thalmann | Buy |
| 2011-07-14 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Opko Health Inc 주식(OPK)의 최신 뉴스
Aug Summary: Will OPKO Health Inc outperform its industry peersBear Alert & AI Enhanced Trading Alerts - baoquankhu1.vn
Profit Review: Is OPKO Health Inc stock trending bullishExit Point & Daily Oversold Bounce Ideas - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Aug EndMonth: What are the future prospects of OPKO Health Inc2026 EndofYear Setup & Expert Approved Trade Ideas - baoquankhu1.vn
Here's why you should hold OPK stock in your portfolio for now - MSN
OPKO Health (NASDAQ:OPK) Sets New 12-Month LowHere's What Happened - MarketBeat
OPKO Health Inc Stock: Business Model, Growth Drivers, and Key Investor Considerations in Diagnostic - AD HOC NEWS
Entera Bio (NASDAQ: ENTX) 2025 loss widens as oral peptide pipeline advances - Stock Titan
An oral bone-building tablet for osteoporosis moves toward Phase 3 - Stock Titan
How The OPKO Health (OPK) Story Is Shifting With Mixed Analyst Signals - Yahoo Finance
OPK (OPKO Health) Shiller PE Ratio : (As of Mar. 26, 2026) - GuruFocus
OPKO Health: The Waiting Game Continues (NASDAQ:OPK) - Seeking Alpha
Movement Recap: Whats the beta of OPKO Health Inc stock2026 PostEarnings & High Win Rate Trade Tips - baoquankhu1.vn
Aug Gainers: What is the PEG ratio of OPKO Health Inc2026 Technicals & Long-Term Growth Stock Strategies - baoquankhu1.vn
ETF Watch: Is OPKO Health Inc stock trending bullish2026 Fed Impact & Verified Technical Trade Signals - baoquankhu1.vn
FOMO Trade: Will OPKO Health Inc benefit from seasonality2026 Price Action Summary & Trade Opportunity Analysis - baoquankhu1.vn
OPKO Health Inc stock faces pressure amid insider buying and Labcorp deal aftermath - AD HOC NEWS
OPKO Health Inc stock faces analyst cuts as earnings outlook darkens amid biotech pressures - AD HOC NEWS
Zacks Research Lowers Earnings Estimates for OPKO Health - MarketBeat
Opko Health Inc. (OPK) builds value through partnerships and innovation - MSN
OPK Technical Analysis & Stock Price Forecast - Intellectia AI
Opko, Prologis, Williams, APA, Paysafe: Insider Moves Exposed - TipRanks
Tranche Update on OPKO Health, Inc.'s Equity Buyback Plan announced on July 18, 2024. - marketscreener.com
Barrington lowers PT on OPKO Health (OPK), keeps a buy - msn.com
Opko Health director Paganelli buys $11,350 in company stock By Investing.com - Investing.com India
OPKO Health (NASDAQ:OPK) Director Buys $11,400.00 in Stock - MarketBeat
Barrington Lowers PT on OPKO Health (OPK), Keeps a Buy - Insider Monkey
Opko Health director Paganelli buys $11,350 in company stock - Investing.com
Opko Health (OPK) director adds 10,000 shares in open-market buy - Stock Titan
OPKO Health (NASDAQ: OPK) director granted 50,000 options at $1.17 - Stock Titan
OPKO Health (NASDAQ: OPK) director reports initial common stock holdings - Stock Titan
Zacks Research Forecasts OPKO Health FY2028 Earnings - MarketBeat
Portfolio Update: What is the dividend yield of OPKO Health Inc2026 Performance Recap & Growth Oriented Trade Recommendations - baoquankhu1.vn
OPKO Health Appoints Subbarao V. Uppaluri, Ph.D. as New Director – SEC 8-K Filing March 2026 - Minichart
OPK SEC FilingsOpko Health 10-K, 10-Q, 8-K Forms - Stock Titan
OPKO Health appoints Subbarao V. Uppaluri to board of directors By Investing.com - Investing.com South Africa
OPKO Health appoints Subbarao V. Uppaluri to board of directors - Investing.com
Opko Health Adds Independent Director to Strengthen Governance - TipRanks
OPKO appoints Subbarao V. Uppaluri to Board following Richard Krasno's passing - TradingView
OPKO Health (OPK) appoints former CFO Subbarao Uppaluri to board - Stock Titan
Here's Why You Should Hold OPK Stock in Your Portfolio for Now - TradingView
OPKO Health (OPK) reports Q4 loss, tops revenue estimates - MSN
Aug Ideas: Is OPKO Health Inc stock forming a cup and handleQuarterly Profit Review & Daily Momentum Trading Reports - baoquankhu1.vn
Market Moves: Is OPKO Health Inc forming bullish engulfing patternsSwing Trade & Community Trade Idea Sharing Platform - baoquankhu1.vn
OPK Earning Date, Earning Analysis and Earning Prediction - intellectia.ai
Trading Recap: Is OPKO Health Inc likely to announce a buyback2026 Pullback Review & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Aug Final Week: Is OPKO Health Inc a strong growth stock2026 Momentum & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Support Test: What is the Moat Score of OPKO Health Inc2026 Chart Watch & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Opko Health Inc (OPK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Opko Health Inc 주식 (OPK) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 21 '25 |
Buy |
1.33 |
580,000 |
768,807 |
216,706,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 20 '25 |
Buy |
1.33 |
580,000 |
771,328 |
216,126,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 19 '25 |
Buy |
1.31 |
580,000 |
759,115 |
215,546,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 18 '25 |
Buy |
1.27 |
533,300 |
678,906 |
214,966,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Oct 31 '25 |
Buy |
1.42 |
150,000 |
213,435 |
214,386,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Aug 08 '25 |
Buy |
1.32 |
675,000 |
891,000 |
214,676,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 10 '25 |
Buy |
1.36 |
125,000 |
169,712 |
214,001,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 08 '25 |
Buy |
1.48 |
125,000 |
184,650 |
213,876,448 |
0.17%
1.11%
자본화:
|
볼륨(24시간):